Indivior Pharmaceuticals, Inc 10-K for FY2024
Indivior Pharmaceuticals, Inc. (INDV)
10-K
2025-03-03
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
Indivior Pharmaceuticals, Inc filed this 10-K on March 3, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.19B
- up 8.7% from $1.09B a year earlier
- Net income
- $2M
- compared with a net loss of $129M a year earlier
- Diluted EPS
- $0.02
- compared with -$0.94 a year earlier